3.38
0.35 (11.55%)
0.35 (11.55%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 30,316 |
|
|||||
News | (1) | ||||||
Day High | 3.36 | Low High |
|||||
Day Low | 3.10 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Lucira Health Inc | LHDX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.36 | 3.10 | 3.36 | 3.19 | 3.03 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
309 | 30,316 | $ 3.21 | $ 97,312 | - | 1.36 - 10.65 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:53 | formt | 200 | $ 3.38 | USD |
Lucira Health Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 134.75M | 39.87M | 17.22M | $ 93.06M | $ -12.42M | -1.86 | -3.40 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | 384.91k | 4.10% |
Lucira Health News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LHDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.26 | 3.58 | 2.89 | 3.19 | 34,680 | 0.12 | 3.68% |
1 Month | 2.53 | 3.58 | 2.52 | 3.02 | 47,726 | 0.85 | 33.6% |
3 Months | 2.18 | 3.58 | 1.36 | 2.19 | 67,328 | 1.20 | 55.05% |
6 Months | 4.80 | 5.67 | 1.36 | 2.99 | 88,585 | -1.42 | -29.58% |
1 Year | 8.289 | 10.65 | 1.36 | 6.38 | 186,281 | -4.91 | -59.22% |
3 Years | 22.10 | 37.985 | 1.36 | 8.23 | 634,955 | -18.72 | -84.71% |
5 Years | 22.10 | 37.985 | 1.36 | 8.23 | 634,955 | -18.72 | -84.71% |
Lucira Health Description
Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications. |